Loading clinical trials...
Loading clinical trials...
Recessive dystrophic epidermolysis bullosa (RDEB) is a hereditary skin disease characterized by cutaneous and mucosa fragility. Blister formations and erosions, resulting in chronic wounds and dystrop...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT07016750 · Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, and more
NCT04213261 · Recessive Dystrophic Epidermolysis Bullosa
NCT06713434 · Junctional Epidermolysis Bullosa, Epidermolysis Bullosa (EB), and more
NCT05725018 · Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, and more
NCT05944250 · Recessive Dystrophic Epidermolysis Bullosa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions